Massivemarkets

SEC Form 4

Thermo Fisher Scientific, Inc. (TMO) insider trading

In the 12 months to Oct 24, 2026, 7 TMO insiders reported open-market sales of $158.1M across 26 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$158.1M
26 filings · 7 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
18 of 26
$89.7M of $158.1M sold (57%)

Who traded TMO, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

TMO daily close from Oct 24, 2025 to Oct 23, 2026, between $438.34 and $696.49, last $673.82. 26 sale and 0 purchase filings by 7 insiders, marked at their filing dates. Marc N. Casper, Chairman & CEO: sold $53.9M across 8 filings, first filed Oct 28, 2025, last Aug 26, 2026. Michel Lagarde, Executive Vice President & COO: sold $51.3M across 3 filings, first filed Nov 14, 2025, last Dec 5, 2025. Michael D. Shafer, Executive Vice President: sold $22.5M across 3 filings, first filed Nov 26, 2025, last Aug 13, 2026. Lisa P. Britt, Sr. VP and Chief HR Officer: sold $16.9M across 4 filings, first filed Nov 10, 2025, last Aug 20, 2026. Frederick M. Lowery, Executive Vice President: sold $8.2M across 1 filing, first filed Dec 3, 2025, last Dec 3, 2025. Gianluca Pettiti, Executive Vice President → President & COO: sold $5.1M across 6 filings, first filed Oct 28, 2025, last Sep 1, 2026. Joseph R. Holmes, VP & Chief Accounting Officer: sold $245.6K across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026.

Largest mark · tap a row for others

Michel Lagarde · Executive Vice President & COO

Filing 1 of 2 within a week · $48,550,370 total

Sale $36,126,126

62,000 shares at $582.68 avg

Filed Dec 4, 2025 · traded Dec 2

Close on filing date $575.24

TMO daily closelast $673.82

Marc N. Casper · Chairman & CEO

$53.9M sold

Michel Lagarde · Executive Vice President & COO

$51.3M sold

Michael D. Shafer · Executive Vice President

$22.5M sold

Lisa P. Britt · Sr. VP and Chief HR Officer

$16.9M sold

Frederick M. Lowery · Executive Vice President

$8.2M sold

Gianluca Pettiti · Executive Vice President → President & COO

$5.1M sold

Joseph R. Holmes · VP & Chief Accounting Officer

$245.6K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Has Thermo Fisher Scientific, Inc.'s CEO sold stock?

Yes. Marc N. Casper (CEO) sold 93,512 shares ($53.9M) between Oct 2025 and Aug 2026, all under a pre-arranged 10b5-1 plan.

Open-market trades

26 filings in the last 12 months
InsiderRoleSoldBoughtFilingsPre-arranged (10b5-1)Last filed
Marc N. CasperChairman & CEO$53.9M—8100% of sales
Michel LagardeExecutive Vice President & COO$51.3M—3—
Michael D. ShaferExecutive Vice President$22.5M—3100% of sales
Lisa P. BrittSr. VP and Chief HR Officer$16.9M—4—
Frederick M. LoweryExecutive Vice President$8.2M—1100% of sales
Gianluca PettitiExecutive Vice President → President & COO$5.1M—6100% of sales
Joseph R. HolmesVP & Chief Accounting Officer$245.6K—1—
Other insider activity (not market trades) · 102 records
  • Option exercises29 records
  • Tax withholding47 records
  • Grants and awards24 records
  • Gifts2 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

Build this yourself

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Agent prompt

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for TMO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Role
The title on each filing. Someone whose title changed shows more than one.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.